SunLink Health Systems In... (SSY)
undefined
undefined%
At close: undefined
0.77
1.02%
After-hours Dec 13, 2024, 08:00 PM EST

Company Description

SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States.

It operates through two segments, Healthcare Services and Pharmacy.

The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit; and a 66-bed extended care and rehabilitation center.

This segment also provides information technology services; and owns unimproved lands.

The Pharmacy segment offers institutional and non-institutional pharmacy services; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services.

SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.

SunLink Health Systems Inc.
SunLink Health Systems Inc. logo
Country United States
IPO Date Mar 18, 1980
Industry Medical - Pharmaceuticals
Sector Healthcare
Employees 1,376
CEO Robert M. Thornton Jr.

Contact Details

Address:
900 Circle 75 Parkway
Atlanta, Georgia
United States
Website https://www.sunlinkhealth.com

Stock Details

Ticker Symbol SSY
Exchange AMEX
Fiscal Year July - June
Reporting Currency USD
CIK Code 0000096793
CUSIP Number 86737U102
ISIN Number US86737U1025
Employer ID 31-0621189
SIC Code 8062

Key Executives

Name Position
Robert M. Thornton Jr. Executive Chairman, Chief Executive Officer & President
Mark J. Stockslager Chief Financial Officer, Principal Accounting Officer & Director
Byron D. Finn CPA President of SunLink ScriptsRX, LLC & Carmichaels Cashway Pharmacy Inc
James J. Mulligan General Counsel & Director Emeritus
Neal Miller President of SunLink HealthCare Technology, Inc
Sheila G. Brockman Vice President
Theresa Mota Secretary

Latest SEC Filings

Date Type Title
Nov 12, 2024 10-Q Quarterly Report
Oct 25, 2024 10-K/A [Amend] Annual Report
Oct 18, 2024 8-K Current Report
Sep 30, 2024 10-K Annual Report
Jul 24, 2024 8-K Current Report
Jul 12, 2024 8-K Current Report
Jun 07, 2024 ARS Filing
Jun 06, 2024 DEF 14A Filing
Jun 05, 2024 8-K Current Report
May 23, 2024 8-K/A [Amend] Current Report